Identification |
Name: | 4H-Pyrimido[6,1-a]isoquinolin-4-one,2,3,6,7-tetrahydro-9,10-dimethoxy-3-methyl-2-[(2,4,6-trimethylphenyl)imino]-,hydrochloride (1:1) |
Synonyms: | 4H-Pyrimido[6,1-a]isoquinolin-4-one,2,3,6,7-tetrahydro-9,10-dimethoxy-3-methyl-2-[(2,4,6-trimethylphenyl)imino]-,monohydrochloride (9CI); HL 725; Trequinsin hydrochloride |
CAS: | 78416-81-6 |
Molecular Formula: | C24H27 N3 O3 . Cl H |
Molecular Weight: | 441.95 |
InChI: | InChI=1/C24H27N3O3.ClH/c1-14-9-15(2)23(16(3)10-14)25-22-13-19-18-12-21(30-6)20(29-5)11-17(18)7-8-27(19)24(28)26(22)4;/h9-13H,7-8H2,1-6H3;1H/b25-22-; |
Molecular Structure: |
|
Properties |
Flash Point: | 325°C |
Boiling Point: | 613.8°C at 760 mmHg |
Biological Activity: | Extremely potent inhibitor of cGMP-inhibited phosphodiesterase (PDE3; IC 50 = 250 pM). Potently inhibits arachidonic acid-induced aggregation of human platelets (IC 50 = 50 pM). Orally active antihypertensive agent; reduces systemic blood pressure in both normotensive and hypertensive animal models. |
Flash Point: | 325°C |
Storage Temperature: | Desiccate at RT |
Safety Data |
|
|